Leuthold Group LLC Has $3.07 Million Stock Holdings in iShares Biotechnology ETF $IBB

Leuthold Group LLC lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 41.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,188 shares of the financial services provider’s stock after purchasing an additional 5,285 shares during the period. Leuthold Group LLC’s holdings in iShares Biotechnology ETF were worth $3,070,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the second quarter valued at $25,000. Cornerstone Planning Group LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter valued at $35,000. Strategic Wealth Advisors LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter valued at $35,000. Parkside Financial Bank & Trust raised its position in iShares Biotechnology ETF by 48.6% during the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after buying an additional 87 shares during the period. Finally, Close Asset Management Ltd raised its position in iShares Biotechnology ETF by 25.5% during the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after buying an additional 70 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $166.83 on Monday. iShares Biotechnology ETF has a 1-year low of $118.51 and a 1-year high of $179.64. The business’s fifty day moving average price is $169.24 and its 200 day moving average price is $169.66.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were given a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.